Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Issuer Symbol
-
MBX on Nasdaq
There are no Buy or Sell transactions made by L.P. Wellington Biomedical Innovation Master Investors (Cayman) II since 12 Feb 2025
Holdings reported by L.P. Wellington Biomedical Innovation Master Investors (Cayman) II for MBX Biosciences, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1,790,122 |
$19,136,404 |
$10.69 |
16 Sep 2024 |
Direct |
|
|
| Series B Preferred Stock |
0 |
|
|
16 Sep 2024 |
Direct |
Common Stock |
|
| Series C Preferred Stock |
0 |
|
|
16 Sep 2024 |
Direct |
Common Stock |
|
Transactions reported by L.P. Wellington Biomedical Innovation Master Investors (Cayman) II for MBX Biosciences, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.